| Recruiting | Excision of Lymph Node Trial (EXCILYNT) (Mel69) Melanoma | N/A | 2023-09-06 |
| Completed | Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With M Melanoma, Ocular Melanoma, Uveal Melanoma | Phase 1 / Phase 2 | 2020-09-28 |
| Terminated | Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors Melanoma, Breast Cancer, Merkel Cell Carcinoma | Phase 1 | 2019-11-21 |
| Completed | Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma Melanoma | Phase 1 / Phase 2 | 2018-11-13 |
| Completed | Safety Study of a Helper Peptide Vaccine Plus Pembrolizumab Melanoma | Phase 1 / Phase 2 | 2016-10-06 |
| Terminated | A Clinical Trial to Evaluate a Melanoma Helper Peptide Vaccine Plus Dabrafenib and Trametinib Melanoma | EARLY_Phase 1 | 2016-04-01 |
| Terminated | Safety Study of a Helper Peptide Vaccine Plus Adjuvant Combinations for the Treatment of Melanoma Melanoma | Phase 1 / Phase 2 | 2015-05-12 |
| Terminated | A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma Melanoma | Phase 1 / Phase 2 | 2015-04-01 |
| Unknown | Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer Pancreatic Cancer | Phase 1 / Phase 2 | 2015-03-01 |
| Completed | Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists Melanoma, Metastatic Melanoma, Mucosal Melanoma | Phase 1 / Phase 2 | 2014-05-01 |
| Completed | Evaluation of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced Maligna Melanoma | Phase 1 | 2013-05-01 |
| Completed | A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients Melanoma | Phase 1 | 2012-10-01 |
| Terminated | Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer Breast Cancer | Phase 1 | 2012-07-01 |
| Completed | Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI Melanoma | EARLY_Phase 1 | 2011-06-01 |
| Terminated | Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine Melanoma | Phase 1 | 2009-11-01 |
| Completed | Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer Breast Neoplasms | Phase 1 | 2009-05-01 |
| Completed | Vaccine Therapy in Treating Patients With Advanced Melanoma Intraocular Melanoma, Malignant Conjunctival Neoplasm, Melanoma (Skin) | Phase 1 | 2008-05-01 |
| Terminated | Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2006-04-13 |
| Completed | Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Melanoma (Skin) | Phase 1 / Phase 2 | 2005-03-01 |
| Completed | Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage Melanoma (Skin) | Phase 1 | 2004-11-04 |
| Completed | Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Sta Melanoma (Skin) | Phase 2 | 2003-09-01 |
| Terminated | Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer Colorectal Cancer | EARLY_Phase 1 | 2003-03-24 |
| Completed | Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-mac Melanoma | Phase 2 | 2000-08-01 |
| Completed | Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-mac Melanoma | N/A | 2000-05-01 |